# FDA recall D-0242-2026

> **Merck Sharp & Dohme LLC** · Class II · drug recall initiated 2025-12-12.

## Product

Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.

## Reason for recall

Presence of particulate matter: potential presence of metal particulates in the product.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0242-2026
- **Recalling firm:** Merck Sharp & Dohme LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-12-12
- **Report date:** 2025-12-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Wilson, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0242-2026

## Citation

> AI Analytics. FDA recall D-0242-2026. Retrieved 2026-08-11 from https://api.ai-analytics.org/recall/D-0242-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*